171 related articles for article (PubMed ID: 26584536)
1. Interpreting the distinct and shared genetic characteristics between Epstein-Barr virus associated and non-associated gastric carcinoma.
Wang X; Zhang Y; Jiang L; Zhou F; Zhai H; Zhang M; Wang J
Gene; 2016 Feb; 576(2 Pt 2):798-806. PubMed ID: 26584536
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes.
Kim SY; Park C; Kim HJ; Park J; Hwang J; Kim JI; Choi MG; Kim S; Kim KM; Kang MS
Gastroenterology; 2015 Jan; 148(1):137-147.e9. PubMed ID: 25254613
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
[TBL] [Abstract][Full Text] [Related]
4. Association of single nucleotide polymorphism rs2065955 of the filaggrin gene with susceptibility to Epstein-Barr virus-associated gastric carcinoma and EBV-negative gastric carcinoma.
Kuang X; Sun L; Liu S; Zhao Z; Zhao D; Liu S; Luo B
Virol Sin; 2016 Aug; 31(4):306-13. PubMed ID: 27535066
[TBL] [Abstract][Full Text] [Related]
5. Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma.
Zhao D; Liu S; Sun L; Zhao Z; Liu S; Kuang X; Shu J; Luo B
Virus Res; 2016 Jul; 220():52-6. PubMed ID: 27071854
[TBL] [Abstract][Full Text] [Related]
6. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
[TBL] [Abstract][Full Text] [Related]
8. P53 deregulation in Epstein-Barr virus-associated gastric cancer.
Ribeiro J; Malta M; Galaghar A; Silva F; Afonso LP; Medeiros R; Sousa H
Cancer Lett; 2017 Sep; 404():37-43. PubMed ID: 28729047
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach.
Fukayama M; Hayashi Y; Iwasaki Y; Chong J; Ooba T; Takizawa T; Koike M; Mizutani S; Miyaki M; Hirai K
Lab Invest; 1994 Jul; 71(1):73-81. PubMed ID: 8041121
[TBL] [Abstract][Full Text] [Related]
10. Expression of CCL21 by EBV-associated gastric carcinoma cells protects CD8
Tang F; Chen JN; Zhang NN; Gong LP; Jiang Y; Feng ZY; Xiao L; Li HG; Du H; Wu B; Shao CK
Pathology; 2018 Oct; 50(6):613-621. PubMed ID: 30149990
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated gastric cancer: A distinct subtype.
Yang J; Liu Z; Zeng B; Hu G; Gan R
Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma.
Chen JN; Jiang Y; Li HG; Ding YG; Fan XJ; Xiao L; Han J; Du H; Shao CK
Virus Res; 2011 Sep; 160(1-2):191-9. PubMed ID: 21723347
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Tumor-Infiltrating Lymphocytes and Tertiary Lymphoid Structures in Epstein-Barr Virus-Associated and -Negative Gastric Carcinoma.
Cheng N; Li P; Cheng H; Zhao X; Dong M; Zhang Y; Zhao P; Chen J; Shao C
Front Immunol; 2021; 12():692859. PubMed ID: 34276684
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Fas/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma.
He D; Xiao L; Chen JN; Liang Q; Shao CK
Chin J Cancer; 2010 Mar; 29(3):283-7. PubMed ID: 20193111
[TBL] [Abstract][Full Text] [Related]
15. Update on Epstein-Barr virus and gastric cancer (review).
Shinozaki-Ushiku A; Kunita A; Fukayama M
Int J Oncol; 2015 Apr; 46(4):1421-34. PubMed ID: 25633561
[TBL] [Abstract][Full Text] [Related]
16. [Significance of the expression of P53 protein and P21WAF1 protein in the gastric carcinoma tissues associated with Epstein-Barr virus (EBV) infections].
Qian J; Li DQ; Zhong F; Li ZX; Lu LC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):1-3. PubMed ID: 16642206
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of locus-specific human lymphocyte antigen class I expression in Epstein-Barr virus-associated gastric cancer: implication for viral-induced immune evasion.
Dutta N; Gupta A; Mazumder DN; Banerjee S
Cancer; 2006 Apr; 106(8):1685-93. PubMed ID: 16541432
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma.
Dong M; Wang HY; Zhao XX; Chen JN; Zhang YW; Huang Y; Xue L; Li HG; Du H; Wu XY; Shao CK
Hum Pathol; 2016 Jul; 53():25-34. PubMed ID: 26980034
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma.
Wang Y; Luo B; Yan LP; Huang BH; Zhao P
World J Gastroenterol; 2005 Jun; 11(21):3234-9. PubMed ID: 15929173
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas.
Zhang YW; Zhao XX; Tan C; Zhang ZG; Jiang Y; Chen JN; Wei HB; Xue L; Li HG; Du H; Shao CK
Oncotarget; 2015 Jan; 6(1):207-20. PubMed ID: 25402957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]